Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Schneider

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncoimmunology|November 20, 2012
Distinct anti-tumoral functions of adaptive immune cells in liver cancerCarlo Schneider, Frank Tacke
Innere Medizin (Heidelberg, Germany)|September 5, 2025
[Paraneoplastic rhabdomyolysis]Carlo Schneider, Patricia Faßbender, Linus Völker
Deutsches Arzteblatt International|August 17, 2022
Dysphagia and DyspneaCarlo Schneider, Patricia Faßbender, Jessica Leers
Clinical Biochemistry|January 31, 2012
Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosisAlexander Koch, Henning W Zimmermann, Christer Baeck, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cellsMaria A González-Carmona, Angela Märten, Per Hoffmann, et al.
Journal of Hepatology|December 15, 2010
Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivoMaria A González-Carmona, Annabelle Vogt, Thomas Heinicke, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter miceFelix Heymann, Patricia M Niemietz, Julia Peusquens, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Cancers|July 20, 2021
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaAnnabelle Vogt, Farsaneh Sadeghlar, Tiyasha H Ayub, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncoimmunology|November 20, 2012
Distinct anti-tumoral functions of adaptive immune cells in liver cancerCarlo Schneider, Frank Tacke
Innere Medizin (Heidelberg, Germany)|September 5, 2025
[Paraneoplastic rhabdomyolysis]Carlo Schneider, Patricia Faßbender, Linus Völker
Deutsches Arzteblatt International|August 17, 2022
Dysphagia and DyspneaCarlo Schneider, Patricia Faßbender, Jessica Leers
Clinical Biochemistry|January 31, 2012
Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosisAlexander Koch, Henning W Zimmermann, Christer Baeck, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cellsMaria A González-Carmona, Angela Märten, Per Hoffmann, et al.
Journal of Hepatology|December 15, 2010
Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivoMaria A González-Carmona, Annabelle Vogt, Thomas Heinicke, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter miceFelix Heymann, Patricia M Niemietz, Julia Peusquens, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Cancers|July 20, 2021
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaAnnabelle Vogt, Farsaneh Sadeghlar, Tiyasha H Ayub, et al.
Pageof 1